Literature DB >> 20352209

Doctor, what does my future hold? The prognostic value of FDG-PET in solid tumours.

Giovanni Lucignani1, Steven M Larson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20352209     DOI： 10.1007/s00259-010-1428-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  21 in total

1.  PET/CT Assessment of Response to Therapy: Tumor Change Measurement, Truth Data, and Error.

Authors:  Paul E Kinahan; Robert K Doot; Michelle Wanner-Roybal; Luc M Bidaut; Samuel G Armato; Charles R Meyer; Geoffrey McLennan
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

2.  F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.

Authors:  Twyla B Bartel; Jeff Haessler; Tracy L Y Brown; John D Shaughnessy; Frits van Rhee; Elias Anaissie; Terri Alpe; Edgardo Angtuaco; Ronald Walker; Joshua Epstein; John Crowley; Bart Barlogie
Journal:  Blood       Date:  2009-05-14       Impact factor: 22.113

Review 3.  Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis.

Authors:  LingLing Pan; Ping Gu; Gang Huang; HuiPing Xue; ShuQi Wu
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-09       Impact factor: 2.566

4.  Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.

Authors:  Gi Jeong Cheon; Min Suk Kim; Jun Ah Lee; Soo-Yong Lee; Wan Hyeong Cho; Won Seok Song; Jae-Soo Koh; Ji Young Yoo; Dong Hyun Oh; Duk Seop Shin; Dae-Geun Jeon
Journal:  J Nucl Med       Date:  2009-08-18       Impact factor: 10.057

5.  Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.

Authors:  Chun-Ta Liao; Joseph Tung-Chieh Chang; Hung-Ming Wang; Shu-Hang Ng; Chuen Hsueh; Li-Yu Lee; Chih-Hung Lin; I-How Chen; Shiang-Fu Huang; Ann-Joy Cheng; Tzu-Chen Yen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-26       Impact factor: 7.038

6.  FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome.

Authors:  Maroun Karam; Ashar Ata; Kevin Irish; Paul J Feustel; Felix M Mottaghy; Sigrid G Stroobants; Gregor E Verhoef; Surya Chundru; Vonda Douglas-Nikitin; Ching-yee Oliver Wong; Lieselot M Brepoels
Journal:  Nucl Med Commun       Date:  2009-10       Impact factor: 1.690

7.  Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose-positron emission tomography in biliary tract carcinoma.

Authors:  Hiroyoshi Furukawa; Hiroki Ikuma; Koiku Asakura; Katsuhiko Uesaka
Journal:  J Surg Oncol       Date:  2009-11-01       Impact factor: 3.454

8.  The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma.

Authors:  Heta Javeri; Lianchun Xiao; Eric Rohren; Jeffrey H Lee; Zhongxing Liao; Wayne Hofstetter; Dipen Maru; Manoop S Bhutani; Stephen G Swisher; Homer Macapinlac; Xuemei Wang; Jaffer A Ajani
Journal:  Cancer       Date:  2009-11-15       Impact factor: 6.860

9.  Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma.

Authors:  P Xie; J-B Yue; Z Fu; R Feng; J-M Yu
Journal:  Ann Oncol       Date:  2009-11-13       Impact factor: 32.976

10.  PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer.

Authors:  Viswam S Nair; Paul G Barnett; Lakshmi Ananth; Michael K Gould
Journal:  Chest       Date:  2009-12-28       Impact factor: 9.410
View more
  4 in total

1.  Multimodal interventional molecular imaging of tumor margins and distant metastases by targeting αvβ3 integrin.

Authors:  Anton Bunschoten; Tessa Buckle; Nils L Visser; Joeri Kuil; Hushan Yuan; Lee Josephson; Alexander L Vahrmeijer; Fijs W B van Leeuwen
Journal:  Chembiochem       Date:  2012-04-13       Impact factor: 3.164

2.  Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer.

Authors:  Mathieu Hatt; Dimitris Visvikis; Olivier Pradier; Catherine Cheze-le Rest
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-11       Impact factor: 9.236

3.  Evaluation of arginine deiminase treatment in melanoma xenografts using (18)F-FLT PET.

Authors:  Lars Stelter; Simon Fuchs; Achim A Jungbluth; Gerd Ritter; Valerie A Longo; Pat Zanzonico; Nathanael Raschzok; Igor M Sauer; John S Bomalaski; Steven M Larson
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

4.  Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials.

Authors:  Eric O Aboagye; Fiona J Gilbert; Ian N Fleming; Ambros J Beer; Vincent J Cunningham; Paul K Marsden; Dimitris Visvikis; Antony D Gee; Ashley M Groves; Laura M Kenny; Gary J Cook; Paul E Kinahan; Melvyn Myers; Larry Clarke
Journal:  Eur Radiol       Date:  2012-04-04       Impact factor: 5.315
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.